ReviewJournal of experimental & clinical cancer research : CR2016

Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic.

Aniello Cerrato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.